Back
Verve Therapeutics Vs. Caribou Biosciences Industry Stock Comparison
Sell
36
VERV
Verve Therapeutics
Last Price:
5.60
Seasonality Move:
-34.1%
Sell
25
CRBU
Caribou Biosciences
Last Price:
1.73
Seasonality Move:
-16.23%
Sell
36
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $5.60. The Score for VERV is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Caribou Biosciences (CRBU)
is a Sell
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $1.73. The Score for CRBU is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- CRBU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $5.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $1.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBU is experiencing slight selling pressure.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 48.86 | Sell |
Chaikin Money Flow: | 756028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.75 - 6.03) | Buy |
Bollinger Bands (100): | (5.07 - 6.69) | Sell |
CRBU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 35.08 | Sell |
Chaikin Money Flow: | -445243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.89 - 2.17) | Sell |
Bollinger Bands (100): | (1.73 - 3.29) | Sell |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.94 | Sell |
20-day SMA: | 5.26 | Buy |
50-day SMA: | 5.93 | Sell |
200-day SMA: | 9.27 | Sell |
8-day EMA: | 5.76 | Sell |
20-day EMA: | 5.65 | Sell |
50-day EMA: | 5.86 | Sell |
200-day EMA: | 8.84 | Sell |
CRBU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.99 | Sell |
20-day SMA: | 2.04 | Sell |
50-day SMA: | 2.05 | Sell |
200-day SMA: | 4.2 | Sell |
8-day EMA: | 1.94 | Sell |
20-day EMA: | 2.03 | Sell |
50-day EMA: | 2.18 | Sell |
200-day EMA: | 3.62 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Verve Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Caribou Biosciences Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |